Cargando…
Targeted therapy of irritable bowel syndrome with anti-inflammatory cytokines
Irritable bowel syndrome (IBS) is a multifactorial disease of which infection, as well as inflammation, has recently been considered as an important cause. Inflammation works as a potential pathway for the pathogenesis of IBS. In this review, we have discussed the targeted therapy of IBS. We used th...
Autores principales: | Kumar, Sunil, Singh, Priyanka, Kumar, Awanish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858303/ https://www.ncbi.nlm.nih.gov/pubmed/34862947 http://dx.doi.org/10.1007/s12328-021-01555-8 |
Ejemplares similares
-
Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015) -
Psychological Interventions for Irritable Bowel Syndrome and Inflammatory Bowel Diseases
por: Ballou, Sarah, et al.
Publicado: (2017) -
Proinflammatory cytokines in irritable bowel syndrome: a comparison with inflammatory bowel disease
por: Mitselou, Antigony, et al.
Publicado: (2020) -
Gut Microbiota-Based Therapies for Irritable Bowel Syndrome
por: Stern, Emily K, et al.
Publicado: (2018) -
Volatomics in inflammatory bowel disease and irritable bowel syndrome
por: Van Malderen, Kathleen, et al.
Publicado: (2020)